Assessment of Organ Failure Risk Predictions in ICU
AI4ICU-Obs
Prospective Assessment of Risk Predictions of Organ Failure in the Intensive Care Unit - Comparing Accuracy of Human and AI Risk Predictions
1 other identifier
observational
499
1 country
1
Brief Summary
During this observational study, the investigators aim to assess the ability of ICU clinicians to predict the risk of impending organ failure and retrospectively compare it to the performance of previously published machine learning models. The central hypothesis of this study is that the treating physician can predict impending organ failure in adult ICU patients with similar accuracy as the best previously publishes machine learning models.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2024
CompletedStudy Start
First participant enrolled
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2026
ExpectedAugust 28, 2025
November 1, 2024
6 months
November 18, 2024
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinician prediction of circulatory failure within 8 hours compared to published ML models
This outcome compares the area under the receiver operating characteristic curve (auROC) for two methods of predicting circulatory failure within 8 hours of each assessment time point: (1) ICU clinicians' risk estimates, and (2) previously published machine learning (ML) models applied retrospectively. For each assessment, we compute the auROC separately for clinicians and for the ML model for the same time points and patients. The difference in auROC (clinician minus ML) is the main measure of interest, evaluated under a non-inferiority framework with a margin of 0.025.
Assessments are collected within the first 72 hours following admission.
Secondary Outcomes (1)
Clinician prediction of respiratory failure within 24 hours compared to published ML models
Assessments are collected within the first 72 hours following admission.
Other Outcomes (6)
Exploratory analysis of clinician prediction of renal failure within 48 hours compared to published ML models
Assessments are collected within the first 72 hours following admission.
Exploratory analysis of clinician mortality prediction compared to published ML models
Assessments are collected within the first 72 hours following admission.
Exploratory analysis of predictive accuracy of treating physicians versus treating nurses
Assessments are collected within the first 72 hours following admission.
- +3 more other outcomes
Study Arms (1)
Adult ICU patients
Adult ICU patients
Eligibility Criteria
Adult Intensive Care Unit at the University Hospital Bern
You may qualify if:
- patient minimum age of 18 years
- emergency admission to the ICU
- arterial line in place
You may not qualify if:
- documented refusal (on the general consent form) to participate to clinical research
- patients with neurologic conditions that impair the patient's level of consciousness (including, but not limited to stroke, traumatic brain injury, intracranial hemorrhage, CNS infections; except polytrauma)
- patients on mechanical circulatory support systems (IABP, VA-ECMO, Impella, VAD) or extracorporeal membrane oxygenation (VV-ECMO) at any time during their ICU stay;
- patients receiving end-of-life care or are admitted for the sole purpose of evaluating organ donation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ETH Zurichlead
- Insel Gruppe AG, University Hospital Berncollaborator
Study Sites (1)
University Hospital Inselspital, Berne
Bern, Canton of Bern, 3010, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Faltys, Dr. med.
Insel Gruppe AG, University Hospital Bern
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2024
First Posted
February 7, 2025
Study Start
November 18, 2024
Primary Completion
May 15, 2025
Study Completion (Estimated)
May 15, 2026
Last Updated
August 28, 2025
Record last verified: 2024-11